pharmacie et médicaments – Suites à donner à l'expérimentation du cannabis thérapeutique

This written question asks the French government about the next steps following the experimentation of therapeutic cannabis. It seeks to understand the planned follow-up actions and policies. The question concerns patients who could benefit from this treatment, healthcare professionals involved, and the pharmaceutical industry. It aims to clarify the future accessibility and regulation of therapeutic cannabis in France.